Bartlett & Co’s Exact Sciences EXAS Stock Holding History

Bartlett & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	–	–	1036
2021 Q1	$0	Hold	3	–	–	﹤0.01%	1089
2020 Q4	$0	Buy	+3	New	+$363	﹤0.01%	1163
2020 Q2	–	Sell	-157	Closed	-$9K	–	839
2020 Q1	$9K	Buy	+157	New	+$12.7K	﹤0.01%	666

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bartlett & Co's EXAS Position: Q2 2021 in Review

Bartlett & Co sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 3 shares.

Bartlett & Co first reported a position in EXAS in Q1 2020 and held it in 3 quarters. The position peaked at $9K in Q1 2020. 622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

Bartlett & Co reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
Bartlett & Co sold 3 Exact Sciences shares in Q2 2021.
Bartlett & Co first reported a position in Exact Sciences in Q1 2020 and held it in 3 quarters.
Bartlett & Co's Exact Sciences position peaked at $9K in Q1 2020.
622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Bartlett & Co's 13F filing for Q2 2021, filed 19 Jul 2021.